First published online December 11, 2006
Journal of Cell Science 119, 2403e (2006)
© The Company of Biologists Limited
Keratin 10 - cancer in the end
Epithelial cells express many keratins, all of which may have specific roles. In the mammalian epidermis, the basal layer (which includes proliferating keratinocytes) expresses keratin 14 (K14), whereas post-mitotic suprabasal keratinocytes express keratin 10 (K10). Because K10 overexpression in the basal layer inhibits keratinocyte proliferation in transgenic mice, it has been proposed that K10 suppresses proliferation in the skin. On p. 5067, Peter Koch and colleagues overturn this idea by showing that expression of K10 end domains (which inhibit cell-cycle progression in vitro) at physiological levels does not inhibit basal keratinocyte proliferation in vivo. The authors have made transgenic mice whose basal keratinocytes express physiological amounts of a chimeric keratin that contains the K14 central domain and the K10 end domains. Skin development is normal in these mice but papillomas form after carcinogen treatment faster than in wild-type mice, partly because apoptosis is suppressed. The authors speculate that K10 normally suppresses cell death in suprabasal keratinocytes to allow them to differentiate, a physiological function missed in experiments in which K10 was overexpressed.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
- An unexpected role for keratin 10 end domains in susceptibility to skin cancer
- Jiangli Chen, Xing Cheng, Maria Merched-Sauvage, Carlos Caulin, Dennis R. Roop, and Peter J. Koch
JCS 2006 119: 5067-5076.
[Abstract]
[Full Text]